Cancer immunotherapy has achieved tremendous successful clinical results and obtained
historic victories in tumor treatments. However, great limitations associated with feeble …

Chiral nanozymes represent an exciting convergence of nanotechnology and enzymatic
catalysis, possessing both the biologically inspired catalytic properties of nanomaterials and …

Insufficient activation of the stimulator of interferon genes (STING) signaling pathway and
profoundly immunosuppressive microenvironment largely limits the effect of cancer …

Multienzyme‐mimicking redox nanozymes capable of efficient reactive oxygen species
(ROS) generation and cellular homeostasis disruption are highly pursued for cancer …

Cancer vaccines have received tremendous attention in cancer immunotherapy due to their
capability to induce a tumor-specific immune response. However, their effectiveness is …

With the economy's globalization and the population's aging, cancer has become the
leading cause of death in most countries. While imposing a considerable burden on society …

Immune checkpoint blockade (ICB) therapy has shown great potential in the treatment of
malignant tumors, but its therapeutic effect on glioblastoma (GBM) is unsatisfactory because …

The immunomodulatory effect of divalent manganese cations (Mn2+), such as activation of
the cGAS− STING pathway or NLRP3 inflammasomes, positions them as adjuvants for …

The cyclic-GMP-AMP synthetase stimulator of interferon genes (cGAS-STING) pathway is a
naturally occurring immune pathway activated by cytosolic DNA. The end products of this …

Radiosensitization efficacy of conventional tumor radiosensitizers has been frequently
limited by insufficient competence for tumor microenvironment (TME) regulation and …